Discriminative stimulus effects in rats of SR-141716 (rimonabant), a cannabinoid CB₁ receptor antagonist

By Järbe Torbjörn   Harris Michele   Li Chen   Liu Qian   Makriyannis Alexandros  

Psychopharmacology, Vol. 177, Iss. 1-2, 2004-12 ,pp. : 35-45

Springer Publishing Company

Access to resources Recommend Favorite

SR 141716A reverses hypotension in advanced cirrhosis

By  

Inpharma, Vol. 1, Iss. 1302, 2001-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Inhibitory effects of SR141716A on G-protein activation in rat brain

By Sim-Selley L.J.   Brunk L.K.   Selley D.E.  

European Journal of Pharmacology, Vol. 414, Iss. 2, 2001-03 ,pp. : 135-143

Elsevier

Access to resources Recommend Favorite

SR 141716A, a cannabinoid receptor antagonist, produces hyperalgesia in untreated mice

By Richardson J.D.   Aanonsen L.   Hargreaves K.M.  

European Journal of Pharmacology, Vol. 319, Iss. 2, 1997-01 ,pp. : 3-4

Elsevier

Access to resources Recommend Favorite

Cannabinoid precipitated withdrawal by the selective cannabinoid receptor antagonist, SR 141716A

By Aceto M.D.   Scates S.M.   Lowe J.A.   Martin B.R.  

European Journal of Pharmacology, Vol. 282, Iss. 1, 1995-08 ,pp. : 1-2

Elsevier

Access to resources Recommend Favorite